Fresenius | FRE - Eigenkapital Und Reserven

Aktienkurs
40.25
Täglich Wechseln
-0.46 -1.13%
Monatlich
-9.57%
Jährlich
1.00%
Q2 Prognose
39.19




Eigenkapital Und Reserven Veränderung Datum
Akzo Nobel EUR 4.88B 222M 2026-03
Alcon AG USD 22.03B 52M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
BASF EUR 33.2B 434M 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Beiersdorf EUR 8.6B 133M 2025-12
DaVita Healthcare Partners USD -651.08M 79.21M 2025-12
Demant DKK 9.84B 446M 2025-12
E.ON EUR 19.26B 5.04B 2025-12
Essilor EUR 38.89B 1.07B 2025-12
Fresenius EUR 18.62B 320M 2025-09
Fresenius Medical Care EUR 249.82M 12.7B 2025-12
Getinge SEK 33.01B 2.75B 2024-12
Givaudan CHF 4.54B 430M 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
GN Store Nord DKK 14.88B 4.33B 2025-12
GRIFOLS EUR 5.29B 108.05M 2025-12
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lonza CHF 9.13B 513M 2025-12
Merck EUR 28.59B 344M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Philips EUR 10.58B 204M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
RWE EUR 37.67B 4.21B 2025-09
Sanofi EUR 72.81B 1.1B 2026-03
Smith & Nephew USD 5.54B 331M 2025-12